Data as of 1:55pm ET
| -0.07 / -2.78%|
The 4 analysts offering 12-month price forecasts for Pernix Therapeutics Holdings Inc have a median target of 2.50, with a high estimate of 5.00 and a low estimate of 2.00. The median estimate represents a +2.04% increase from the last price of 2.45.
The current consensus among 5 polled investment analysts is to Hold stock in Pernix Therapeutics Holdings Inc. This rating has held steady since November, when it was downgraded from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.